Annexon Inc. (ANNX) NASDAQ

$13.70 -0.92 (-6.29%)

Market Cap: $525.74M

As of 11/26/21 01:00 PM EST. Market closed.

(ANNX)

Annexon Inc. (ANNX) NASDAQ

$13.70 -0.92 (-6.29%)

Market Cap: $525.74M

As of 11/26/21 01:00 PM EST. Market closed.

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant ... read more

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is deploying a rigorous, biomarker-driven development strategy designed to improve the probability of technical success over shorter development timelines. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
48
Address
.
KEY STATS
Open
$13.72
Previous Close
$14.62
Days Range
$13.45 - $14.61
52 week range
$13.03 - $38.01
Volume
143,134
Avg. Volume (30 days)
232,287
Market Cap
$525.74M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
38,374,846
Open
$13.72
Previous Close
$14.62
Days Range
$13.45 - $14.61
52 week range
$13.03 - $38.01
Volume
143,134
Avg. Volume (30 days)
232,287
Market Cap
$525.74M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
38,374,846

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ANNEXON INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Love Douglas President & CEO Nov 11, 2021 Option Exercise $1.54 100,942 155,503 100,942 Nov 15, 2021, 06:05 PM
Love Douglas President & CEO Sep 16, 2021 Option Exercise $1.41 7,500 10,572 7,500 Sep 20, 2021, 05:46 PM
Love Douglas President & CEO Sep 16, 2021 Sale $22.05 7,500 165,341 0 Sep 20, 2021, 05:46 PM
Yednock Ted EVP & Chief Scientific Officer Sep 13, 2021 Option Exercise $1.68 16,190 27,225 16,190 Sep 15, 2021, 06:35 PM
Yednock Ted EVP & Chief Scientific Officer Sep 13, 2021 Sale $20.00 16,190 323,860 0 Sep 15, 2021, 06:35 PM
Lew Jennifer EVP & Chief Financial Officer Sep 13, 2021 Option Exercise $7.49 3,500 26,210 5,500 Sep 15, 2021, 06:35 PM
Lew Jennifer EVP & Chief Financial Officer Sep 13, 2021 Sale $20.01 3,500 70,034 2,000 Sep 15, 2021, 06:35 PM
Yednock Ted EVP & Chief Scientific Officer Jun 03, 2021 Option Exercise $1.41 15,000 21,144 15,000 Jun 07, 2021, 04:47 PM
Yednock Ted EVP & Chief Scientific Officer Jun 03, 2021 Sale $21.49 15,000 322,325 2,184 Jun 07, 2021, 04:47 PM
Love Douglas President & CEO Apr 01, 2021 Option Exercise $1.41 500 705 500 Apr 02, 2021, 12:31 PM
Love Douglas President & CEO Mar 31, 2021 Option Exercise $1.41 7,102 10,011 7,102 Apr 02, 2021, 12:31 PM
Love Douglas President & CEO Apr 01, 2021 Sale $28.08 500 14,041 300 Apr 02, 2021, 12:31 PM
Love Douglas President & CEO Mar 31, 2021 Sale $28.11 7,102 199,621 0 Apr 02, 2021, 12:31 PM
Love Douglas President & CEO Mar 30, 2021 Option Exercise $1.41 3,750 5,286 3,750 Mar 31, 2021, 04:04 PM
Love Douglas President & CEO Mar 29, 2021 Option Exercise $1.41 3,750 5,286 3,750 Mar 31, 2021, 04:04 PM
Love Douglas President & CEO Mar 30, 2021 Sale $24.52 3,750 91,966 1,850 Mar 31, 2021, 04:04 PM
Love Douglas President & CEO Mar 29, 2021 Sale $25.42 3,750 95,334 900 Mar 31, 2021, 04:04 PM
Yednock Ted EVP & Chief Scientific Officer Mar 25, 2021 Option Exercise $1.68 16,175 27,148 16,175 Mar 29, 2021, 05:10 PM
Yednock Ted EVP & Chief Scientific Officer Mar 25, 2021 Sale $28.80 16,175 465,770 5,917 Mar 29, 2021, 05:10 PM
Keswani Sanjay EVP & Chief Medical Officer Mar 24, 2021 Option Exercise $7.49 3,995 29,917 3,995 Mar 26, 2021, 05:52 PM
Keswani Sanjay EVP & Chief Medical Officer Mar 24, 2021 Sale $30.17 3,995 120,512 0 Mar 26, 2021, 05:52 PM
Lew Jennifer EVP & Chief Financial Officer Mar 23, 2021 Option Exercise $7.49 5,000 37,443 7,000 Mar 25, 2021, 07:31 PM
Lew Jennifer EVP & Chief Financial Officer Mar 23, 2021 Sale $28.44 5,000 142,176 5,600 Mar 25, 2021, 07:31 PM
Clarus Lifesciences III, L.P. 10% Owner Jul 28, 2020 Buy $17.00 200,000 3,400,000 2,730,635 Jul 30, 2020, 08:00 PM
Bain Capital Life Sciences Investors, LLC 10% Owner Jul 28, 2020 Buy $17.00 400,000 6,800,000 3,241,628 Jul 28, 2020, 04:45 PM
Lew Jennifer EVP & Chief Financial Officer Jul 28, 2020 Buy $17.00 2,000 34,000 2,000 Jul 28, 2020, 04:18 PM
Satter Muneer A Director Jul 28, 2020 Buy $17.00 200,000 3,400,000 1,954,978 Jul 28, 2020, 04:17 PM
Flynn James E 10% Owner Jul 28, 2020 Buy $17.00 350,000 5,950,000 808,914 Jul 28, 2020, 12:54 PM
Flynn James E 10% Owner Jul 28, 2020 Buy $17.00 350,000 5,950,000 808,914 Jul 28, 2020, 12:54 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Love Douglas President & CEO 11/11/2021 155,503
Love Douglas President & CEO 09/16/2021 10,572
Love Douglas President & CEO 09/16/2021 165,341
Yednock Ted EVP & Chief Scientific Officer 09/13/2021 27,225
Yednock Ted EVP & Chief Scientific Officer 09/13/2021 323,860
Lew Jennifer EVP & Chief Financial Officer 09/13/2021 26,210
Lew Jennifer EVP & Chief Financial Officer 09/13/2021 70,034
Yednock Ted EVP & Chief Scientific Officer 06/03/2021 21,144
Yednock Ted EVP & Chief Scientific Officer 06/03/2021 322,325
Love Douglas President & CEO 04/01/2021 705
Love Douglas President & CEO 03/31/2021 10,011
Love Douglas President & CEO 04/01/2021 14,041
Love Douglas President & CEO 03/31/2021 199,621
Love Douglas President & CEO 03/30/2021 5,286
Love Douglas President & CEO 03/29/2021 5,286
Love Douglas President & CEO 03/30/2021 91,966
Love Douglas President & CEO 03/29/2021 95,334
Yednock Ted EVP & Chief Scientific Officer 03/25/2021 27,148
Yednock Ted EVP & Chief Scientific Officer 03/25/2021 465,770
Keswani Sanjay EVP & Chief Medical Officer 03/24/2021 29,917
Keswani Sanjay EVP & Chief Medical Officer 03/24/2021 120,512
Lew Jennifer EVP & Chief Financial Officer 03/23/2021 37,443
Lew Jennifer EVP & Chief Financial Officer 03/23/2021 142,176
Clarus Lifesciences III, L.P. 10% Owner 07/28/2020 3,400,000
Bain Capital Life Sciences Investors, LLC 10% Owner 07/28/2020 6,800,000
Lew Jennifer EVP & Chief Financial Officer 07/28/2020 34,000
Satter Muneer A Director 07/28/2020 3,400,000
Flynn James E 10% Owner 07/28/2020 5,950,000
Flynn James E 10% Owner 07/28/2020 5,950,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
03/31/2021
0.26%
2Q

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
0.26%
2Q